WIC
SGMO

Woodmont Investment Counsel’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Woodmont Investment Counsel’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-675
Closed -$3K – 533
2016
Q3 		$3K Buy
+675
New +$3.43K ﹤0.01% 619
2016
Q2 		– Sell
-675
Closed -$4K – 404
2016
Q1 		$4K Hold
675
– – ﹤0.01% 472
2015
Q4 		$6K Hold
675
– – ﹤0.01% 460
2015
Q3 		$4K Buy
+675
New +$5.57K ﹤0.01% 476

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

Woodmont Investment Counsel's SGMO Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2016, closing a stake of 675 shares — an estimated $3K sold.

Woodmont Investment Counsel first reported a position in SGMO in Q3 2015 and held it in 4 quarters. The position peaked at $6K in Q4 2015. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.

  • Woodmont Investment Counsel reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2016 after selling out during the quarter.
  • Woodmont Investment Counsel sold 675 SANGAMO THERAPEUTICS INC shares in Q4 2016, an estimated $3K.
  • Woodmont Investment Counsel first reported a position in SANGAMO THERAPEUTICS INC in Q3 2015 and held it in 4 quarters.
  • Woodmont Investment Counsel's SANGAMO THERAPEUTICS INC position peaked at $6K in Q4 2015.
  • 126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.